Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exicure, Inc. - Common Stock (NQ:XCUR)

5.590 +0.270 (+5.08%)
Streaming Delayed Price Updated: 12:21 PM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exicure, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
EXICURE SHAREHOLDER ALERT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In ExicureTo Contact Him Directly To Discuss Their Options 
Via NewMediaWire
Topics Regulatory Compliance
News headline image
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers SCYNEXIS (NASDAQ:SCYX) stock rose 15.69% to $7.15 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 1.2 million shares... 
Via Benzinga
News headline image
Exicure's Return on Invested Capital Overview ↗
Benzinga Pro data, Exicure (NASDAQ:XCUR) reported Q3 sales of $-3.68 thousand. Earnings fell to a loss of $23.08 million, resulting in a 66.51% decrease from last quarter. In Q2... 
Via Benzinga
News headline image
Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
From Exicure, Inc.
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
EXICURE SHAREHOLDER ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
EQUITY ALERT: Rosen Law Firm Encourages Exicure, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – XCUR
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
80 Biggest Movers From Yesterday ↗
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... 
Via Benzinga
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
EXICURE INVESTOR ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
53 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8... 
Via Benzinga
News headline image
Why Are Exicure Shares Trading At All Time Low? ↗
Exicure Inc (NASDAQ: XCUR) has filed a Form 12b-25 with the U.S. SEC in connection with its Form 10-Q for the period ended September 30, 2021. On November 9, 2021... 
Via Benzinga
Topics Regulatory Compliance
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Good morning, trader! Start your day off the right way with a breakdown of the biggest pre-market stock movers for Tuesday. 
Via InvestorPlace
News headline image
36 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Exicure Files Form 12b-25
From Exicure, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Kiromic BioPharma (NASDAQ:KRBP) ... 
Via Benzinga
News headline image
Exicure to Present at Upcoming Scientific Conferences
From Exicure, Inc.
Via Business Wire
News headline image
Exicure to Present at Upcoming Scientific Conferences
From Exicure, Inc.
Via Business Wire
News headline image
Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
From Exicure, Inc.
Via Business Wire
News headline image
Exicure to Present at the Benzinga Healthcare Small Cap Conference
From Exicure, Inc.
Via Business Wire
News headline image
Exicure to Participate in Upcoming Scientific Conferences
From Exicure, Inc.
Via Business Wire
News headline image
Exicure to Participate in Upcoming Investor Conferences
From Exicure, Inc.
Via Business Wire
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.